As of November 2024, Harbin Gloria Pharmaceuticals has a market cap of $577.42M. This makes Harbin Gloria Pharmaceuticals the world's 10567th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $611.56M | -21.51% |
2023 | $779.20M | -1.18% |
2022 | $788.51M | -12.71% |
2021 | $903.38M | -9.06% |
2020 | $993.40M | 5.61% |
2019 | $940.63M | 8.21% |
2018 | $869.23M | -59.36% |
2017 | $2.14B | -16.69% |
2016 | $2.57B | -17.98% |
2015 | $3.13B | 27.37% |
2014 | $2.46B | 41.03% |
2013 | $1.74B | 108.00% |
2012 | $837.77M | - |